Erweiterte Suche

Zurzeit ist Claudio Descalzi Chief Executive Officer, Director & GM bei Eni SpA. Herr Descalzi ist außerdem im Vorstand des Teatro alla Scala und von Mothers2mothers (Großbritannien) sowie Mitglied des Generalrats von Confindustria. In der Vergangenheit bekleidete Herr Descalzi die Position des Vice Chairman & Managing Director bei Nigerian Agip Oil Co. Ltd, Mitglied des National Petroleum Council, Vorsitzender bei Eni (UK) Ltd. und Präsident bei Associazione Mineraria Italiana. Er erwarb einen Bachelor-Abschluss an der Universität Mailand.

Martin Descalzi is currently working as the Head of Operations at Hudson River Trading LLC.

Douglas Descalzi is currently the Head of Research & Development at Bayer Medical Care, Inc. He previously worked as the Vice President & General Manager of IV Solutions at Omnicell, Inc. Mr. Descalzi completed his undergraduate degree at the University of Notre Dame, his MBA at the University of Virginia, and his graduate degree at Virginia Polytechnic Institute & State University.

Claudio has served as Managing Director at Omega Funds since 2016 and is a member of the firm’s investment committee.
Claudio joined Omega Funds from NeoMed Management, which he joined in 2001 and where he became a Partner in 2004.
He has over 20 years’ experience of venture capital investing in healthcare in Europe and the US.
Prior to NeoMed, Claudio was a Venture Partner with Genevest Consulting Group SA in Geneva.
He has academic research experience in molecular biology from the Max Planck Institute in Germany, and the University of Connecticut, USA. Claudio has an MBA from Erasmus University, the Netherlands, and a Ph.D.
degree in Genetics from the University of Pavia, Italy.